FDA recall record

Dr. Reddy's Laboratories Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and recall — FDA D-0271-2022

Failed dissolution specifications

Class IIIclassification
D-0271-2022official record ID
Dec 15, 2021report date

Recall record at a glance

Official recordD-0271-2022
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmDr. Reddy's Laboratories, Inc.
Report dateDec 15, 2021
Recall initiation dateNov 12, 2021
Quantity2184 cartons
LocationPrinceton, NJ, United States

Official product description

Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 30 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0638-1242-07.

Why the product was recalled

Failed dissolution specifications

Distribution information

USA Nationwide.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: N/A. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.